Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corp's (NYSE: CGC) is likely to be supported by growth in the Canadian recreation business, continued progress by the strategic units and improving profitability, according to Cantor Fitzgerald. The Canopy Growth Analyst: Pablo Zuanic maintained a Neutral rating for Canopy Growth, while raising the price target from CA$28 to CA$29.

Cantor Raises Canopy Growth Target After September Quarter Print

Aurora Cannabis

Tilray Brands

Earnings are out, and what went up just came back down.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Wilted This Morning

Beyond Meat

McDonald's

JPMorgan Chase & Co

Beyond Meat, McDonald's, Canopy Growth and JPMorgan were our top stock trades for Tuesday. Now, let's look at the charts to see why.

4 Top Stock Trades for Tuesday: BYND, MCD, CGC, JPM

Cannabis stocks continued their post-election rally Monday, as two Canadian industry leaders, Canopy Growth Corp. and Aurora Cannabis Inc. posted earnings, amid rising hopes for U.S. reform under President-elect Democrat Joe Biden.

Cannabis Watch: Cannabis stocks rally anew as Canopy and Aurora post results with Tilray still to come

Canopy Growth Corporation (CGC) CEO David Klein on Q2 2021 Results - Earnings Call Transcript

Canopy Growth Corp (TSE: WEED) said on Monday that its loss in the fiscal second quarter came in smaller than expected. The company also reported revenue that topped analysts' estimates.

Canopy Growth says its loss came in smaller than expected in Q2

There was good news from nearly every corner.

3 Ways Canopy Growth Crushed It With Its Q2 Results

Canopy Growth (CGC) news for Monday includes results from the cannabis company's fiscal second quarter of 2020 boosting CGC stock up. The post Canopy Growth News: 5 Things CGC Stock Investors to Know Today appeared first on InvestorPlace.

Canopy Growth News: 5 Things CGC Stock Investors to Know Today

Zynerba Pharmaceuticals

Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB) consolidated net revenue of CA$67.8 million ($52.3 million) for the first quarter of fiscal 2021, being up by around CA$300,000 from the fourth quarter of fiscal 2020.

Earnings Update: Aurora, Canopy Growth, Canopy Rivers And Zynerba Each Post Results

Canopy Growth Corp. (NYSE: CGC) reported second-quarter fiscal 2021 results before markets opened Monday.

Aurora Cannabis, Canopy Growth Earnings Are Disconnected From Current Share Price

Aphria

Pot stocks are on fire from election headlines and today's vaccine announcement from Pfizer. But rallies this big need time to mature.

3 Pot Stocks to Fade Into 2021

Aphria, Aurora Cannabis, and Canopy Growth are bolting higher today on the slim possibility of friendlier marijuana laws at the federal level in the United States.

Why Pot Stocks Are Crushing It Today

Canopy Growth Corp.'s U.S.-listed shares soared 13% in premarket trade Monday, after the Canadian cannabis company posted a smaller-than-expected loss for its fiscal second quarter and revenue that beat estimates. Smith Falls, Ontario-based Canopy posted a loss of C$32.06 million ($24.6 million), or 9 cents a share, for the quarter to Sept.

Canopy Growth shares jump 13% premarket after cannabis company posts smaller-than-expected loss

Achieved record quarterly net revenue of $135 million Net Loss of $97 million; Adjusted EBITDA loss of $86 million, a 43% improvement versus Q2 FY20 Implementing initiatives to capture $150-$200 million of savings across our cost structure Increased market share by 200 basis points in...

Canopy Growth Reports Second Quarter Fiscal 2021 Financial Results

This pot stock might be on a rocky path now, but there's still light at the end of the tunnel.

Why This 1 Marijuana Stock Could Bring Life-Changing Returns

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Cronos Group

The legality of cannabis can differ greatly, depending on where you live.

A State-by-State Look at Where Marijuana Is Legal

New York mulls legalizing weed, and marijuana investors cheer.

Why Marijuana Stocks Are Hopping on Friday

Shares of Aurora Cannabis have more than doubled since Election Day after several states voted to legalize some form of marijuana use.

Aurora Cannabis, other pot stocks surge as marijuana legalization spreads in the US

Canopy Growth (CGC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Should You Buy Canopy Growth (CGC) Ahead of Earnings?

Canada's legal cannabis sales are moving higher by 25% per month which should translate into increased revenues across the board for cannabis producers. Canopy Growth's main products in Canada should reap the rewards of these higher increases with well-positioned distribution and partnerships.

Cannabis In Canada Is Soaring And So Should Canopy Growth

Cannabis stocks are rising to new heights as the smoke begins to clear around the 2020 election. Shares in big weed companies soared on Thursday as investors began to price in a victory for pot-friendly presidential hopeful Joe Biden, even as five US states — including the conservative red state Mississippi — approved measures to.

Marijuana stocks surge as investors bet on a more weed-friendly US

The undoubtedly refreshing beverages are going on sale in the marijuana company's native Canada.

Canopy Growth Rolls Out Its First CBD-Spiked Beverages

In an exclusive conversation, Canopy Growth CEO David Klein shares details of the cannabis company's first CBD SKU in Canada.

Canopy Growth CEO On Launch Of CBD Beverage Line Quatreau: ‘Our First Foray Into Mood Modulation'

It's the impact of the U.S. elections -- but with a different twist this time.

Why Aurora Cannabis, Canopy Growth, and Tilray Stocks Are Rebounding Today

Share prices of most large publicly traded marijuana stocks dropped Wednesday, in a range of a modest 0.4% for Aphria Inc.

News for Canopy Growth Stock (CGC)